160 related articles for article (PubMed ID: 37280656)
21. NFAT5 Regulated by STUB1, Facilitates Malignant Cell Survival and p38 MAPK Activation by Upregulating AQP5 in Chronic Lymphocytic Leukemia.
Chen BL; Li Y; Xu S; Nie Y; Zhang J
Biochem Genet; 2021 Aug; 59(4):870-883. PubMed ID: 33544297
[TBL] [Abstract][Full Text] [Related]
22. Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.
Gandhirajan RK; Staib PA; Minke K; Gehrke I; Plickert G; Schlösser A; Schmitt EK; Hallek M; Kreuzer KA
Neoplasia; 2010 Apr; 12(4):326-35. PubMed ID: 20360943
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of KNTC1 Inhibits the Proliferation, Migration and Tumorigenesis of Human Bladder Cancer Cells and Induces Apoptosis.
Huang H; Fan X; Qiao Y; Yang M; Ji Z
Crit Rev Eukaryot Gene Expr; 2021; 31(1):49-60. PubMed ID: 33639055
[TBL] [Abstract][Full Text] [Related]
24. TOSO interacts with SYK and enhances BCR pathway activation in chronic lymphocytic leukemia.
Zhang YR; Yu Z; Xiong WJ; Liu XX; Liu HM; Cui R; Wang Q; Chen WM; Qiu LG; Yi SH
Chin Med J (Engl); 2020 Sep; 133(17):2090-2097. PubMed ID: 32784334
[TBL] [Abstract][Full Text] [Related]
25. STAT3 promotes chronic lymphocytic leukemia progression through upregulating SMYD3 expression.
Ma W; Zhang Y; Qi Y; Guo S
Arch Med Sci; 2019 Sep; 15(5):1163-1175. PubMed ID: 31572461
[TBL] [Abstract][Full Text] [Related]
26. Constitutively Photomorphogenic 1 Reduces the Sensitivity of Chronic Lymphocytic Leukemia Cells to Fludarabine Through Promotion of Ubiquitin-Mediated P53 Degradation.
Fu C; Shi X; Gong Y; Wan Y; Sun Z; Shi H; Wang Z; Marinaccio C; Crispino JD; Xu K
Cell Physiol Biochem; 2018; 50(6):2314-2328. PubMed ID: 30423551
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia.
Zhang Y; Zhou X; Li Y; Xu Y; Lu K; Li P; Wang X
Oncogene; 2018 Oct; 37(41):5520-5533. PubMed ID: 29895969
[TBL] [Abstract][Full Text] [Related]
28. CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia.
Hu X; Han Y; Liu J; Wang H; Tian Z; Zhang X; Zhang Y; Wang X
Exp Hematol Oncol; 2023 Jan; 12(1):6. PubMed ID: 36635772
[TBL] [Abstract][Full Text] [Related]
29. Biological relevance of ZNF224 expression in chronic lymphocytic leukemia and its implication IN NF-kB pathway regulation.
Catapano R; Sepe L; Toscano E; Paolella G; Chiurazzi F; Barbato SP; Bruzzese D; Arianna R; Grosso M; Romano S; Romano MF; Costanzo P; Cesaro E
Front Mol Biosci; 2022; 9():1010984. PubMed ID: 36425656
[TBL] [Abstract][Full Text] [Related]
30. BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.
Perini GF; Feres CCP; Teixeira LLC; Hamerschlak N
Curr Treat Options Oncol; 2021 Jun; 22(8):66. PubMed ID: 34110507
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia.
Hortal AM; Oeste CL; Cifuentes C; Alcoceba M; Fernández-Pisonero I; Clavaín L; Tercero R; Mendoza P; Domínguez V; García-Flores M; Pintado B; Abia D; García-Macías C; Navarro-Bailón A; Bustelo XR; González M; Alarcón B
Mol Cancer; 2022 Feb; 21(1):35. PubMed ID: 35120522
[TBL] [Abstract][Full Text] [Related]
32. shRNA‑mediated knockdown of KNTC1 suppresses cell viability and induces apoptosis in esophageal squamous cell carcinoma.
Liu CT; Min L; Wang YJ; Li P; Wu YD; Zhang ST
Int J Oncol; 2019 Mar; 54(3):1053-1060. PubMed ID: 30628654
[TBL] [Abstract][Full Text] [Related]
33. KNTC1 knockdown suppresses cell proliferation of colon cancer.
Zhengxiang Z; Yunxiang T; Zhiping L; Zhimin Y
3 Biotech; 2021 Jun; 11(6):262. PubMed ID: 33996374
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA CRNDE suppressing cell proliferation is regulated by DNA methylation in chronic lymphocytic leukemia.
Ni J; Hong J; Li Q; Zeng Q; Xia R
Leuk Res; 2021 Jun; 105():106564. PubMed ID: 33857783
[TBL] [Abstract][Full Text] [Related]
35. Synaptotagmin 7 and SYNCRIP proteins are ubiquitously expressed in the rat brain and co-localize in Purkinje neurons.
Tratnjek L; Živin M; Glavan G
J Chem Neuroanat; 2017 Jan; 79():12-21. PubMed ID: 27771350
[TBL] [Abstract][Full Text] [Related]
36. CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cells.
Shcherbina V; Gordiienko I; Shlapatska L; Gluzman D; Sidorenko S
Neoplasma; 2021 Jul; 68(4):760-769. PubMed ID: 33904315
[TBL] [Abstract][Full Text] [Related]
37. Expression and regulation of CacyBP/SIP in chronic lymphocytic leukemia cell balances of cell proliferation with apoptosis.
Fu C; Wan Y; Shi H; Gong Y; Wu Q; Yao Y; Niu M; Li Z; Xu K
J Cancer Res Clin Oncol; 2016 Apr; 142(4):741-8. PubMed ID: 26603518
[TBL] [Abstract][Full Text] [Related]
38. Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia.
Ganguly S; Home T; Yacoub A; Kambhampati S; Shi H; Dandawate P; Padhye S; Saluja AK; McGuirk J; Rao R
Oncotarget; 2015 Oct; 6(31):31767-79. PubMed ID: 26397138
[TBL] [Abstract][Full Text] [Related]
39. Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model.
Shukla A; Cutucache CE; Sutton GL; Pitner MA; Rai K; Rai S; Opavsky R; Swanson PC; Joshi SS
Exp Hematol; 2016 Jan; 44(1):30-7.e1. PubMed ID: 26435347
[TBL] [Abstract][Full Text] [Related]
40. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
